EU-Startups recently provided a summary of key funding activities across Europe during the week of May 18-22, 2026, emphasizing the robust nature of the startup ecosystem in the region.
Among the standout funding events, UK-based Primer, a payments startup, successfully raised €86.2 million in a Series C funding round aimed at bolstering its AI capabilities and expanding its presence in the US market. In a related move, Málaga's Magnific initiated a €10 million fund to assist creative teams in transitioning AI projects into viable production campaigns.
In the biotech arena, Swiss startup ALP Bio attracted €1.9 million to further develop its immune organoid and AI platform. Additionally, Kurma Partners launched Biofund IV, securing €215 million to support European biotech initiatives from its Paris base.
Other notable funding included Norway's Roboxi, which raised €13 million for innovations in airport automation and robotics, and the UK’s AI startup Scope, which garnered €17.3 million, led by Index Ventures, to improve industrial inspection processes.
This weekly report highlights not only the financial investments but also the ongoing innovation within technology sectors across Europe, particularly in AI and biotech, indicating a promising trajectory for future growth in these fields.